Fig. 1
From: ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer
Combined nuclear pERK/p-p38 score stratifies CSS in BRAF mutant CRC patients (n = 782). Kaplan–Meier curves showing associations between (a) pERK or (b) the combined nuclear pERK/p-p38 score and CSS in BRAF WT and BRAF mutant patients with CRC
